Current Affairs - Science - Discussion

The USFDA approved a new drug called Pretomanid. It is only the third new anti-TB drug approved for use by USFDA in over 40 years. Pretomanid is part of the same class of drugs as delamanid - one of the other two TB drugs approved in the last half century, developed by pharmaceutical corporation Otsuka. The drug is used over a six-month period in concert with two other TB mediciations.